278 related articles for article (PubMed ID: 18254487)
41. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
Wong JT; Nagy CS; Krinzman SJ; Maclean JA; Bloch KJ
J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
[TBL] [Abstract][Full Text] [Related]
42. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
Asero R
Clin Exp Allergy; 2005 Jun; 35(6):713-6. PubMed ID: 15969659
[TBL] [Abstract][Full Text] [Related]
43. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review.
Asero R; Bavbek S; Blanca M; Blanca-Lopez N; Cortellini G; Nizankowska-Mogilnicka E; Quaratino D; Romano A; Sanchez-Borges M; Torres-Jaen MJ
Int Arch Allergy Immunol; 2013; 160(2):126-33. PubMed ID: 23018315
[TBL] [Abstract][Full Text] [Related]
44. Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance.
Asero R
Int Arch Allergy Immunol; 2007; 144(3):226-30. PubMed ID: 17579281
[TBL] [Abstract][Full Text] [Related]
45. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
Eisen GM; Goldstein JL; Hanna DB; Rublee DA
Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
[TBL] [Abstract][Full Text] [Related]
47. The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study.
Celebioglu E; Karakaya G; Kalyoncu AF
Allergol Immunopathol (Madr); 2013; 41(3):163-8. PubMed ID: 23031656
[TBL] [Abstract][Full Text] [Related]
48. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity.
Knowles SR; Drucker AM; Weber EA; Shear NH
Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236
[TBL] [Abstract][Full Text] [Related]
49. A prospective, randomized, double-blind comparison between parecoxib and ketorolac for early postoperative analgesia following nasal surgery.
Leykin Y; Casati A; Rapotec A; Dal Sasso M; Barzan L; Fanelli G; Pellis T
Minerva Anestesiol; 2008 Sep; 74(9):475-9. PubMed ID: 18414367
[TBL] [Abstract][Full Text] [Related]
50. Safety of celecoxib in patients with adverse reactions to nimesulide.
Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
[No Abstract] [Full Text] [Related]
51. Parecoxib as an alternative in COX-2 hypersensitivity.
Colanardi MC; Nettis E; Traetta P; Delle Donne P; Ferrannini A; Vacca A
Int J Immunopathol Pharmacol; 2008; 21(1):233-5. PubMed ID: 18336751
[TBL] [Abstract][Full Text] [Related]
52. Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
Nettis E; Colanardi MC; Ferrannini A; Vacca A; Tursi A
Ann Allergy Asthma Immunol; 2005 Nov; 95(5):438-42. PubMed ID: 16312166
[TBL] [Abstract][Full Text] [Related]
53. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
Liccardi G; Cazzola M; De Giglio C; Manfredi D; Piscitelli E; D'Amato M; D'Amato G
J Investig Allergol Clin Immunol; 2005; 15(4):249-53. PubMed ID: 16433205
[TBL] [Abstract][Full Text] [Related]
54. [Tolerability of a selective cyclooxygenase-2-inhibitor (rofecoxib) in patients with intolerance reactions to nonsteroidal anti-inflammatory agents].
Zollner TM; Ahlbach S; Kaufmann R; Boehncke WH
Dtsch Med Wochenschr; 2001 Apr; 126(14):386-8. PubMed ID: 11332239
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response.
Doña I; Blanca-López N; Cornejo-García JA; Torres MJ; Laguna JJ; Fernández J; Rosado A; Rondón C; Campo P; Agúndez JA; Blanca M; Canto G
Clin Exp Allergy; 2011 Jan; 41(1):86-95. PubMed ID: 21155908
[TBL] [Abstract][Full Text] [Related]
56. Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients.
Matucci A; Parronchi P; Vultaggio A; Rossi O; Brugnolo F; Maggi E; Romagnani S
Allergy; 2004 Oct; 59(10):1133-4. PubMed ID: 15355480
[No Abstract] [Full Text] [Related]
57. Drug-induced angioedema without urticaria: prevalence and clinical features.
Leeyaphan C; Kulthanan K; Jongjarearnprasert K; Dhana N
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):685-91. PubMed ID: 19925599
[TBL] [Abstract][Full Text] [Related]
58. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
[TBL] [Abstract][Full Text] [Related]
59. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
[TBL] [Abstract][Full Text] [Related]
60. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
